Влияние пандемии COVID-19 на онкологическую практику

Влияние пандемии COVID-19 на онкологическую практику

Автор: Каприн Андрей Дмитриевич, Гамеева Елена Владимировна, Поляков Александр Андреевич, Корниецкая Анна Леонидовна, Рубцова Наталья Алефтиновна, Феденко Александр Александрович

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Передовая статья

Статья в выпуске: 3 т.19, 2020 года.

Бесплатный доступ

Проведен детальный, систематический обзор данных мировой литературы, включающий все аспекты, которые отражают влияние пандемии COVID-19 на онкологическую практику. Поиск информационных источников произведен в системах Pubmed, MedLine, Scopus, Web of Science, РИНЦ. Проанализированы данные ретроспективных и проспективных клинических исследований. В обзоре отражен опыт российских и зарубежных исследователей, представлены данные о влиянии COVID-19 на онкологических пациентов, смертности и прогнозе у онкологических больных, инфицированных COVID-19, возможностях лечения COVID-19, а также представлен нетипичный случай течения данной инфекции у онкобольного. На сегодняшний день выделены группы повышенного риска инфицирования новым коронавирусом, к ним относятся и пациенты c онкологическими заболеваниями. Несмотря на пандемию, лечение онкологических пациентов необходимо продолжать, так как наличие опухолевого процесса не допускает задержки в проведении терапии. Мировое онкологическое сообщество активно продолжает разрабатывать рекомендации по оптимальному ведению онкологических больных в условиях пандемии. Наиболее актуальные из них изложены в данной статье.

Еще

Пандемия, онкология, лекарственное лечение опухолей, онкогематология, солидные опухоли

Короткий адрес: https://sciup.org/140254352

IDR: 140254352   |   DOI: 10.21294/1814-4861-2020-19-3-5-22

Список литературы Влияние пандемии COVID-19 на онкологическую практику

  • Guan W.J., Ni Z. Y, Hu Y, Liang W.H., Ou C.Q., He JX., LiuL., ShanH., Lei C.L., Hui D.S.C., Du B., Li L.J., Zeng G., Yuen K.Y., Chen R.C., Tang C.L., Wang T., Chen P.Y., Xiang J., Li S.Y., Wang J.L., Liang Z.J., Peng Y.X., Wei L., Liu Y., Hu Y.H., Peng P., Wang J.M., Liu J.Y., Chen Z., Li G., Zheng Z.J., Qiu S.Q., Luo J., Ye C.J., Zhu S.Y., Zhong N.S.; China Medical Treatment Expert Group for COVID-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-20. doi: 10.1056/NEJMoa2002032.
  • Li Q., GuanX., WuP., WangX., ZhouL., Tong Y., RenR., LeungK.S.M., LauE.H.Y., Wong J.Y.,XingX.,XiangN., Wu Y., Li C., ChenQ.,LiD., Liu T., Zhao J., Liu M., Tu W., Chen C., Jin L., Yang R., Wang Q., Zhou S., Wang R., Liu H., Luo Y., Liu Y., Shao G., Li H., Tao Z., Yang Y., Deng Z., Liu B., Ma Z., Zhang Y., Shi G., Lam T.T.Y., Wu J.T., Gao G.F., Cowling B.J., Yang B., Leung G.M., Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26; 382(13): 1199-1207. doi: 10.1056/NEJMoa2001316.
  • Chen N., Zhou M, Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15; 395(10223): 507-513. doi: 10.1016/S0140-6736(20)30211-7.
  • Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce H., Spitters C., Ericson K., Wilkerson S., TuralA., Diaz G., Cohn A., Fox L., Patel A., Gerber S.I., Kim L., Tong S., Lu X., Lindstrom S., PallanschM.A., Weldon W.C., BiggsH.M., Uyeki T.M., Pillai S.K.; Washington State 2019-nCoVCase Investigation Team. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020 Mar 5; 382(10): 929-936. doi: 10.1056/NEJMoa2001191.
  • Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., GuX., Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5.
  • WangD, Hu B, Hu C, Zhu F., LiuX, Zhang J, WangB, XiangH, Cheng Z, Xiong Y, Zhao Y,, Li Y,, Wang X,,, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-9. doi: 10.1001/ jama.2020.1585.
  • Chan JF, Yuan S, KokKH, To KK, Chu H, Yang J, Xing F, Liu J, Yip C,C, Poon RW, Tsoi H,W, Lo S,K, Chan K,H, Poon VK, Chan WM, Ip J,D, Cai J,P, Cheng V,C, Chen H, Hui C,K, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb 15; 395(10223): 514-523. doi: 10.1016/S0140-6736(20)30154-9.
  • Hoehl S, Rabenau H, Berger A,, Kortenbusch M, Cinatl J,, Bojkova D, Behrens P,, Böddinghaus B, Götsch U, Naujoks E, Neumann P, SchorkJ, Tiarks-JungkP,,, WalczokA,EickmannM, VehreschildM.J.G.T., Kann G, Wolf T, GottschalkR, CiesekS, Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. N Engl J Med. 2020 Mar 26; 382(13): 1278-1280. doi: 10.1056/NEJMc2001899.
  • WangH, ZhangL, Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020 Apr; 21(4): e181. doi: 10.1016/S1470-2045(20)30149-2.
  • YouB, Ravaud A,, Canivet A,, Ganem G, GiraudP,,, GuimbaudR, Kaluzinski L, Krakowski I, Mayeur D, Grellety T, Lotz JP The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol. 2020; 21(5): 619-21. doi: 10.1016/S1470-2045(20)30204-7.
  • Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W,, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 Mar; 21(3): 335-337. doi: 10.1016/S1470-2045(20)30096-6.
  • Burki T,K, Cancer care in the time of COVID-19. Lancet Oncol. 2020 May; 21(5): 628. doi: 10.1016/S1470-2045 (20)30201-1.
  • Burki T,K, Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020 May; 21(5): 629-630. doi: 10.1016/S1470-2045(20)30217-5.
  • Wang Z, Wang J, He J, Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China. JAMA Oncol. 2020; 6(5): 631632. doi: 10.1001/jamaoncol.2020.1198.
  • ESMO, Cancer patient management during the COVID-19 pandemic [Internet]. URL: https://www.esmo.org/guidelines/cancer-patient-management-during-the-COVID-19-pandemic?hit=ehp&page=1 (cited 01.04.2020).
  • Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D,, Cruz C, Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol. 2020 Apr 21: S09237534(20)39303-0. doi: 10.1016/j.annonc.2020.04.006.
  • Временные методические рекомендации: профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) [Интернет]. URL: https://static1.rosminzdrav.ru/system/attachments/attach-es/000/050/116/original/28042020_%D0%9CR_COVID-19_v6.pdf (дата обращения: 01.04.2020) [Temporary methodological recommendations: prevention, diagnosis and treatment of new coronaviral infection (COVID-19) [Internet]. URL: https://static1.rosminzdrav.ru/system/attachments/at-taches/000/050/116/original/28042020_%D0%9CR_COVID-19_v6.pdf (cited 01.04.2020). (in Russian)].
  • I of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. URL: https://www.who.int/publications-detail/ report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(COVID-19) (cited 01.04.2020).
  • 19.Mehta V, GoelS, KabarritiR, ColeD, Goldfinger M,Acuna-Vil-laorduna A, PradhanK, ThotaR, Reissman S, Sparano JA, GartrellBA, Smith R,V, Ohri N, Garg M, Racine A,D, Kalnicki S, Perez-Soler R, HalmosB, VermaA, Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System. Cancer Discov. 2020 May 1: CD-20-0516. doi: 10.1158/2159-8290.CD-20-0516.
  • WangM, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W,, Xiao G, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar; 30(3): 269-271. doi: 10.1038/s41422-020-0282-0.
  • Metlay J,P, Waterer G,W, Long A,C, Anzueto A, BrozekJ, Croth-ers K, Cooley LA, Dean N,C, Fine MJ, Flanders SA, Griffin MR, Metersky M,L,, Musher D,M,, Restrepo M,I,, Whitney C,G. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1; 200(7): e45e67. doi: 10.1164/rccm.201908-1581ST.
  • Russell C,D, Millar J,E, Baillie J,K, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. The Lancet. 2020; 395(10223): 473-475. doi: 10.1016/S0140-6736(20)30317-2.
  • Поддубная ИВ, Сычев ДА. Особенности ведения онкологических пациентов во время пандемии коронавирусной инфекции COVID-19 [Интернет]. URL: https://rosoncoweb.ru/news/ COVID-19/2020/04/07-2/module.pdf (дата обращения: 01.04.2020). [Poddubnaya I.V., Sychev D.A. Features of managing of oncological patients during a pandemic of coronavirus infection COVID-19. [Internet]. URL: https://rosoncoweb.ru/news/COVID-19/2020/04/07-2/module.pdf (дата обращения: 01.04.2020). (in Russian)].
  • Hung I.F., Lung K.C., Tso E.Y., Liu R., Chung T.W., Chu M.Y., Ng Y.Y, Lo J, Chan J., Tam A.R., Shum H.P, Chan K, Wu A.K., Sin K.M, Leung W.S., Law W.L, Lung D.C., Sin S, Yeung P, Yip C.C, ZhangR.R., Fung A,Y, Yan E,Y, Leung K,H, Ip JD, Chu A,W, Chan WM, Ng A,C, Lee R, Fung K, Yeung A, Wu TC, Chan J,W, Yan W,W, Chan WM, Chan J,F, Lie A,K, Tsang O,T, Cheng VC, Que T,L, Lau C,S, ChanK,H, To K,K, Yuen K,Y, Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 May 30; 395(10238): 1695-1704. doi: 10.1016/S0140-6736(20)31042-4.
  • COVID-19: Elective Case Triage Guidelines for Surgical Care. American College of Surgeons. March 24, 2020. https://www.facs.org/ COVID-19/clinical-guidance/elective-case/.
  • Mayor S, COVID-19: impact on cancer workforce and delivery of care. Lancet Oncol. 2020 May; 21(5): 633. doi: 10.1016/S1470-2045(20)30240-0.
  • Simcock R, Thomas TV,, Estes C, Filippi A,R, Katz MA, Pereira IJ, SaeedH, COVID-19: Global radiation oncology's targeted response for pandemic preparedness. Clin Transl Radiat Oncol. 2020 Mar 24; 22: 55-68. doi: 10.1016/j.ctro.2020.03.009.
  • Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) у онкологических больных [Интернет]. URL: https://oncology-association.ru/files/pdf/2020/COVID.pdf (дата обращения: 01.04.2020). [Prevention, diagnostics and treatment of new coronavirus infection (COVID-19) in oncologic patients [Internet]. URL: https://oncology-association.ru/files/pdf/2020/COVID.pdf (cited: 01.04.2020). (in Russian)].
  • ESMO management and treatment adapted recommendations in the COVID-19 era: primary brain tumours [Internet]. URL: https://www. esmo.org/guidelines/cancer-patient-management-during-the-COVID-19-pandemic/primary-brain-tumours-in-the-COVID-19-era (cited: 01.04.2020).
  • ESMO management and treatment adapted recommendations in the COVID-19 era: diffuse large B-cell lymphoma, mantle cell lymphoma and aggressive T-cell lymphomas [Internet]. URL: https://www.esmo.org/ guidelines/cancer-patient-management-during-the-COVID-19-pandemic/ haematological-malignancies-dlbcl-mcl-and-aggressive-t-cell-lymphoma-in-the-COVID-19-era (cited: 01.04.2020).
  • ESMO management and treatment adapted recommendations in the COVID-19 era: multiple myeloma [Internet]. URL: https://www.esmo.org/ guidelines/cancer-patient-management-during-the-COVID-19-pandemic/ haematological-malignancies-multiple-myeloma-in-the-COVID-19-era (cited: 01.04.2020).
  • ESMO management and treatment adapted recommendations in the COVID-19 era: breast cancer [Internet]. URL: https://www.esmo.org/ guidelines/cancer-patient-management-during-the-COVID-19-pandemic/ breast-cancer-in-the-COVID-19-era (cited: 01.04.2020).
  • ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer [Internet]. URL: https://www.esmo.org/ guidelines/cancer-patient-management-during-the-COVID-19-pandemic /gastrointestinal-cancers-colorectal-cancer-crc-in-the-COVID-19-era (cited: 01.04.2020).
  • ESMO management and treatment adapted recommendations in the COVID-19 era: renal cell cancer [Internet]. URL: https://www. esmo.org/guidelines/cancer-patient-management-during-the-COVID-19-pandemic/genitourinary-cancers-renal-cell-cancer-in-the-COVID-19-era (cited: 01.04.2020).
  • ESMO management and treatment adapted recommendations in the COVID-19 era: prostate cancer [Internet]. URL: https://www. esmo.org/guidelines/cancer-patient-management-during-the-COVID-19-pandemic/genitourinary-cancers-prostate-cancer-in-the-COVID-19-era (cited: 01.04.2020).
  • ESMO management and treatment adapted recommendations in the COVID-19 era: epithelial ovarian cancer [Internet]. URL: https://www. esmo.org/guidelines/cancer-patient-management-during-the-COVID-19-pandemic/gynaecological-malignancies-epithelial-ovarian-cancer-in-the-COVID-19-era (cited: 01.04.2020).
  • ESMO management and treatment adapted recommendations in the COVID-19 era: melanoma [Internet]. URL: https://www.esmo.org/ guidelines/cancer-patient-management-during-the-COVID-19-pandemic/ melanoma-in-the-COVID-19-era (cited: 01.04.2020).
  • PenelN, BonvalotS, Minard V, OrbachD, GouinF, CorradiniN, BrahmiM, Marec-BérardP, Briand S, GasparN, Llacer C, Carrére S, Dufresne A, Le Cesne A, Blay J,Y. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak. Ann Oncol. 2020 Apr 9; 31(7): 965-966. doi: 10.1016/j.annonc.2020.03.308.
  • Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy. 2020 Apr; 12(5): 269-273. doi: 10.2217/imt-2020-0067.
  • Mei H., Dong X., Wang Y., Tang L., Hu Y. Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan. Lancet Oncol. 2020 May; 21(5): 634-636. doi: 10.1016/S1470-2045(20)30238-2.
  • Главный внештатный онколог Минздрава: рак не уходит на карантин [Интернет]. URL: https://tass.ru/interviews/8391689 (дата обращения: 01.04.2020). [Chief freelance oncologist of the Ministry of Health: cancer does not go to quarantine [Internet]. URL: https://tass.ru/ interviews/8391689 (cited 01.04.2020). (in Russian)].
  • ГеращенкоЯ.Л. Обзор клинических рекомендаций по ведению пациентов с подтвержденной коронавирусной болезнью (COVID-19) выпущенных Американским национальным центром иммунизации и респираторных заболеваний (NCIRD). Русский медицинский журнал [Интернет]. URL: https://www.rmj.ru/articles/infektsiya/obzor-klinicheskikh-rekomendatsiy-po-vedeniyu-patsientov-s-podtverzhdennoy-koronavirusnoy-boleznyu-COVID-19-vypushchennykh-amerikanskim-natsionalnym-tsentrom-immunizatsii-i-respiratornykh-zabolevaniy-ncird/ (дата обращения: 01.04.2020). [Gerashchenko Ya.L. Review of clinical guidelines for the management of patients with confirmed coronavirus disease (COVID-19) issued by the American national center for immunization and respiratory diseases (NCIRD). Russian Medical Journal [Internet]. URL: https:// www.rmj.ru/articles/infektsiya/obzor-klinicheskikh-rekomendatsiy-po-vedeniyu-patsientov-s-podtverzhdennoy-koronavirusnoy-boleznyu-COVID-19-vypushchennykh-amerikanskim-natsionalnym-tsentrom-immunizatsii-i-respiratornykh-zabolevaniy-ncird/ (cited 01.04.2020). (in Russian)].
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp